About Us

Faith is a professor at Imperial College London and the current President of the International Union of Immunological Societies, the first African and only second woman in this role. She serves on Boards and Expert Committees at the WHO, Wellcome, UKRI, MVI-PATH & BactiVac, and has a global footprint as a keynote & motivational speaker. Faith is passionate about emerging African scientists as key agents of change, delivering the health interventions our continent urgently needs. 

Anca brings over ten years of international experience in fostering innovation and supporting startup investments. Her proven track record includes delivering strategic insights and practical solutions to both C-suite executives and Board members within diverse corporate and entrepreneurial networks.

James is a Senior Scientist with substantial expertise in molecular biology, protein design, engineering, and expression. He has over 15 years of experience in malaria sero-epidemiology.

Dorecas is is Head of Health Systems and Research Ethics (HSRE) Department at KWTRP and Associate Professor at Oxford University. Her research covers the ethical and social-cultural issues on complex topics such as bio-banking, controlled human infection studies and pandemic preparedness & response in African contexts. 

Edwine is the Deputy Executive Director of the KWTRP and Head of the Health Economics Research Unit. He is a Visiting Professor of Health Economics at Oxford University with research spanning health financing, the efficiency & equity of health systems, the economic evaluation of healthcare interventions & translation to policy. 

Marianne is a Pharmacologist with >10-years’ experience of research governance across the pharmaceutical industry & in research institutes in Kenya & the UK. She manages regulatory services at the KEMRI-Wellcome Trust Research Program, including major international clinical trials.

George is the Deputy Executive Director of the KWTRP and Professor of Vaccinology at Oxford University. His One Health Vaccine Program at the Jenner Institute develops vaccines for simultaneous deployment in humans and animals. He developed a novel chimpanzee adenovirus vectored Rift Valley Fever vaccine that is highly efficacious in multiple target livestock species and has shown promise in human clinical trials in the UK and East Africa.